Ligand Reports Second Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Ligand Reports Second Quarter 2018 Financial Results

Ligand Pharma (LGND) Tops Q2 EPS by 25c, Beats on Revenues; Boosts FY18 EPS/Revenue Outlook

August 6, 2018 4:03 PM EDT

Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $2.59, $0.25 better than the analyst estimate of $2.34. Revenue for the quarter came in at $90 million versus the consensus estimate of $82.2 million.

The second quarter was punctuated by major positive corporate events that are driving our financial success and highlighting the potential of our business... More